Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea

BACKGROUND: Plasmodium vivax malaria has a persistent liver stage that causes relapse, and introducing tafenoquine to suppress relapse could aid in disease eradication. Therefore, we assessed the impact of tafenoquine introduction on P. vivax malaria incidence and performed a cost-benefit analysis f...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Jiyeon, Kim, Jung Ho, Kim, Jong-Dae, Kim, Changsoo, Choi, Jun Yong, Lee, Jeehyun, Yeom, Joon-Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274106/
https://www.ncbi.nlm.nih.gov/pubmed/35818703
http://dx.doi.org/10.3346/jkms.2022.37.e212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274106/
https://www.ncbi.nlm.nih.gov/pubmed/35818703
http://dx.doi.org/10.3346/jkms.2022.37.e212

Ejemplares similares